Neuro Kinetics, Inc. in Pittsburgh, Pennsylvania receives FDA inspection

Neuro Kinetics, Inc. in Pittsburgh, Pennsylvania receives FDA inspection
0Comments

Neuro Kinetics, Inc. in Pittsburgh, Pennsylvania was inspected by the Food and Drug Administration (FDA) on July 2 for radiation control and health safety act and received four citations, according to data posted on the FDA’s official website.

The FDA website indicates that the citations were delivered to the company as follows:

‘Design validation did not ensure the device conforms to defined user needs and intended uses.’

‘Acceptance criteria were not established prior to the performance of validation activities.’

‘Procedures for acceptance of incoming product have not been adequately established.’

‘Procedures have not been adequately established to control product that does not conform to specified requirements.’

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency that is primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.



Related

Kyle Diamantas, J.D., Deputy Commissioner for Human Foods of FDA

FDA inspects South Italy Imports, LLC in Bethlehem on March 17

South Italy Imports, LLC underwent an FDA inspection in Bethlehem on March 17 focused on foodborne biological hazards, as indicated by data published on the FDA’s website.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA conducted inspections of 3 companies in cities located in Lehigh County in March

There were three companies in cities associated with Lehigh County that received three FDA inspections in March, according to the U.S. Food and Drug Administration.

Dr. Mehmet Oz CMS Administrator

Northampton records $582,418 in Medicaid spending on ambulance, transport services in 2024

Medicaid spending for Ambulance and Other Transport Services and Supplies rose by 89% in Northampton in 2024, reflecting increased service utilization and shifts in reimbursement methods.